CN102078387A - Traditional Chinese medicine for treating fibroid and ovarian cyst - Google Patents
Traditional Chinese medicine for treating fibroid and ovarian cyst Download PDFInfo
- Publication number
- CN102078387A CN102078387A CN2010105037748A CN201010503774A CN102078387A CN 102078387 A CN102078387 A CN 102078387A CN 2010105037748 A CN2010105037748 A CN 2010105037748A CN 201010503774 A CN201010503774 A CN 201010503774A CN 102078387 A CN102078387 A CN 102078387A
- Authority
- CN
- China
- Prior art keywords
- grams
- chinese medicine
- ovarian cyst
- traditional chinese
- medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a traditional Chinese medicine for treating fibroid and ovarian cyst, which comprises the following components by weight: 60 grams of peach seed and safflower, 60 grams of tree peony bark, 60 grams of red paeony root, 60 grams of cassia twig, 60 grams of Indian buead and 60 grams of mongolian dandelion herb, wherein the accuracy of dose of the traditional Chinese medicine is +/-10 percent of each medicine. The traditional Chinese medicine is mainly used for treating fibroid and ovarian cyst, has the effects of soothing liver, regulating the flow of qi, promoting blood circulation and removing blood stasis, clearing heat and detoxicating and regulating endocrine comprehensively and activating blood circulation and internal organs, has safe and stable medicinal effect and high cure rate, and does not have toxic or side effect.
Description
Technical field
The present invention relates to a kind of gynopathic medicine, especially a kind of Chinese medicine for the treatment of hysteromyoma ovarian cyst disease.
Background technology
In gynecological's case, hysteromyoma, ovarian cyst are a kind of common benign tumors of female sex organ, and the possibility that cancerates is arranged more, are common in 20-50 year women, and ovarian cyst is divided into clinically: qi stagnation and blood stasis type, cold-damp stasis type, gas stasis of blood heat-transformation type; Hysteromyoma; Hysteromyoma is divided into clinically: qi stagnation and blood stasis type, deficiency of YIN liver-fire type, QIXUELIANGXU type, caused by hepatic stagnation qi stagnation and damp heat downward flowing type, existing Drug therapy hysteromyoma ovarian cyst is unsatisfactory.
Summary of the invention
In order to solve the more unfavorable problems of the sick treatment of hysteromyoma ovarian cyst, the invention provides a kind of Chinese medicine for the treatment of hysteromyoma ovarian cyst disease, the Chinese medicine of this kind treatment hysteromyoma ovarian cyst disease cures mainly hysteromyoma ovarian cyst, and hepar sulfuris is regulated the flow of vital energy, blood circulation promoting and blood stasis dispelling, heat-clearing and toxic substances removing, endocrine regulation is lived gas face blood comprehensively, enlivens internal organs, the drug effect safety and stability, the cure rate height, without any side effects.
Concrete proportioning of the present invention is: pink 60 grams, Cortex Moutan 60 gram, Radix Paeoniae Rubra 60 grams, Ramulus Cinnamomi 60 grams, Poria 60 grams, Herba Taraxaci 60 grams, the degree of accuracy of the dose of this medicine be each medicine ± 10%.
The pharmacology of the Chinese medicine of this treatment hysteromyoma ovarian cyst disease is: pink, Cortex Moutan: activating blood circulation and dissipating phlegm, removing heat from blood, eliminating carbuncle skin ulcer; Ramulus Cinnamomi, Poria: expelling pathogenic factors from muscles stimulates the menstrual flow, YANG invigorating activating QI diuresis; Radix Paeoniae Rubra: clearing away heat and cooling blood, eliminating stasis to stop pain; Herba Taraxaci: heat-clearing and toxic substances removing, dispersing swelling and dissipating binds.
Preparing process of the present invention: go into pot and fry and do standbyly pink, put into sieve with frying do pink with Cortex Moutan, Radix Paeoniae Rubra, Ramulus Cinnamomi, Poria, Herba Taraxaci, dash with the clear water sieve, pull the back oven dry out, grind to form fine powder, machine is made pill and is got final product.
Administrated method of the present invention is: every day twice, and each 5-6 gram, taking one month is a course of treatment.
The invention has the beneficial effects as follows: the Chinese medicine of this kind treatment hysteromyoma ovarian cyst disease cures mainly hysteromyoma ovarian cyst, and hepar sulfuris is regulated the flow of vital energy, blood circulation promoting and blood stasis dispelling, heat-clearing and toxic substances removing, endocrine regulation is lived gas face blood comprehensively, enlivens internal organs, the drug effect safety and stability, the cure rate height, without any side effects.
Specific embodiment
Through over 3 years, the clinical practice to 100 these patients of example treatment has obtained curative effect preferably, and total effective rate reaches 95%, and details are as follows for relevant clinical treatment situation:
1. patient profile: select projects such as medical history, the state of an illness, age and original therapy method.
2. patient originates: with general hospital patient and professional OH patient.
3. case is gone into the group standard, and according to the clinical manifestation and the pathological characters branch of treatment hysteromyoma ovarian cyst, the age is not limit, stop using before the treatment other various medicines and therapeutic modality.
4. preparing process: go into pot and fry and do standbyly pink, put into sieve with frying do pink with Cortex Moutan, Radix Paeoniae Rubra, Ramulus Cinnamomi, Poria, Herba Taraxaci, dash with the clear water sieve, pull the back oven dry out, grind to form fine powder, machine is made pill and is got final product.
5. administrated method: oral every day twice, each 5-6 gram, taking one month is a course of treatment.
6. efficacy evaluation
1. recovery from illness: hysteromyoma ovarian cyst disease symptoms disappears.
2. remarkable: curing does not afterwards have recurrence more than 1 year.
3. effective: hysteromyoma ovarian cyst disease symptoms significantly reduces.
4. invalid: change not quite before and after the treatment, or once taking a turn for the better, after return to symptom before the treatment again.
7. efficacy analysis:
1. the course of disease: 2 months～11 months is 45 examples, and 1 year～2 years is 25 examples, is 30 examples more than 2 years.
2. age group: 27～30 years old 30 example, 31～40 years old 35 example, 41～55 years old 35 example.
3. prepare the dose scheme for first kind: pink 66 grams, Cortex Moutan 66 grams, Radix Paeoniae Rubra 66 grams, Ramulus Cinnamomi 66 grams, Poria 66 restrain, Herba Taraxaci 66 grams.
The efficacy analysis of this scheme, administration time are 1～2 course of treatment.
| Patient's type | Recovery from illness | Significantly | Effectively | Invalid |
| Patients with mild 50 examples | 40 | 7 | 2 | 1 |
| Moderate patient's 35 examples | 30 | 2 | 2 | 1 |
| Severe patient 15 examples | 12 | 1 | 1 | 1 |
The scheme of second kind of preparation dose: pink 60 grams, Cortex Moutan 60 grams, Radix Paeoniae Rubra 60 grams, Ramulus Cinnamomi 60 grams, Poria 60 grams, Herba Taraxaci 60 grams.
The efficacy analysis of this scheme, administration time are 1～2 course of treatment.
| Patient's type | Recovery from illness | Significantly | Effectively | Invalid |
| Patients with mild 45 examples | 35 | 8 | 1 | 1 |
| Moderate patient's 40 examples | 35 | 3 | 1 | 1 |
| Severe patient 15 examples | 10 | 3 | 1 | 1 |
The scheme of the third preparation dose: pink 54 grams, Cortex Moutan 54 grams, Radix Paeoniae Rubra 54 grams, Ramulus Cinnamomi 54 grams, Poria 54 grams, Herba Taraxaci 54 grams.
The efficacy analysis of this scheme, administration time are 1～3 course of treatment.
| Patient's type | Recovery from illness | Significantly | Effectively | Invalid |
| Patients with mild 50 examples | 40 | 8 | 1 | 1 |
| Moderate patient's 40 examples | 35 | 3 | 1 | 1 |
| Severe patient 10 examples | 6 | 1 | 1 | 2 |
By Drug therapy hysteromyoma ovarian cyst sufferer of the present invention, received satisfied curative effect.The symptom of this disease is a lot, and this clinical experiment is divided into " slightly ", " moderate " and " seriously " several types according to clinical characters, and this clinical experiment is to carry out jointly at general hospital and special outpatient clinic.
Before this group case treatment, during most of patients was carried out, the treatment of doctor trained in Western medicine mode, but all do not obtain curative effect preferably, especially Western medicine is for oral administration, and toxic and side effects is bigger.In taking the process of medicine of the present invention, cut out Western medicine or other treats this sick medicine.
The Chinese medicine of this kind treatment hysteromyoma ovarian cyst disease cures mainly hysteromyoma ovarian cyst, and hepar sulfuris is regulated the flow of vital energy, blood circulation promoting and blood stasis dispelling, heat-clearing and toxic substances removing, endocrine regulation is lived gas face blood comprehensively, enlivens internal organs, the drug effect safety and stability, the cure rate height, without any side effects, cure rate reaches 95%.
Claims (2)
1. Chinese medicine for the treatment of hysteromyoma ovarian cyst disease, it is characterized in that: concrete proportioning of the present invention is: pink 60 grams, Cortex Moutan 60 gram, Radix Paeoniae Rubra 60 grams, Ramulus Cinnamomi 60 grams, Poria 60 grams, Herba Taraxaci 60 grams, the degree of accuracy of the dose of this medicine be each medicine ± 10%.
2. a kind of Chinese medicine for the treatment of hysteromyoma ovarian cyst disease according to claim 1, it is characterized in that: preparing process of the present invention be with pink go into pot fry do standby, put into sieve with frying do pink with Cortex Moutan, Radix Paeoniae Rubra, Ramulus Cinnamomi, Poria, Herba Taraxaci, dash with the clear water sieve, pull the back oven dry out, grind to form fine powder, machine is made pill and is got final product.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2010105037748A CN102078387A (en) | 2010-10-08 | 2010-10-08 | Traditional Chinese medicine for treating fibroid and ovarian cyst |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2010105037748A CN102078387A (en) | 2010-10-08 | 2010-10-08 | Traditional Chinese medicine for treating fibroid and ovarian cyst |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN102078387A true CN102078387A (en) | 2011-06-01 |
Family
ID=44084712
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2010105037748A Pending CN102078387A (en) | 2010-10-08 | 2010-10-08 | Traditional Chinese medicine for treating fibroid and ovarian cyst |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102078387A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111166845A (en) * | 2018-10-24 | 2020-05-19 | 广西小咕噜生物科技有限公司 | External traditional Chinese medicine ointment for treating hysteromyoma |
-
2010
- 2010-10-08 CN CN2010105037748A patent/CN102078387A/en active Pending
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111166845A (en) * | 2018-10-24 | 2020-05-19 | 广西小咕噜生物科技有限公司 | External traditional Chinese medicine ointment for treating hysteromyoma |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101961449B (en) | Traditional Chinese medicine for treating tinea corporis | |
| CN102078462A (en) | Asthma relieving medicament | |
| CN101983644A (en) | Medicament for treating sequelae of apoplexy | |
| CN102078472A (en) | Medicament for treating verruca wart | |
| CN101983652A (en) | Traditional Chinese medicine for treating scapulohumeral periarthritis | |
| CN1883642A (en) | Medicine for treating mammary glands hyperplasia | |
| CN101979035A (en) | Medicament for treating gynecological abnormal leucorrhea | |
| CN101961455A (en) | Traditional Chinese medicine for treating chronic colitis disease | |
| CN102078432A (en) | Medicament for treating skin itch | |
| CN101983682A (en) | Medicament for treating female climacteric metancholia | |
| CN103083387A (en) | Congestion-eliminating pain-relieving plaster | |
| CN101979061A (en) | Antiemetic medicine | |
| CN102078387A (en) | Traditional Chinese medicine for treating fibroid and ovarian cyst | |
| CN103191369A (en) | Chinese medicinal composition for treating mammary gland hyperplasia | |
| CN101983712A (en) | Novel medicament for treating coronary heart disease | |
| CN111388564B (en) | Traditional Chinese medicine for treating bradyarrhythmia | |
| CN103536745A (en) | Traditional Chinese medicinal watered pills for treating hyperplasia of mammary glands | |
| CN101953943A (en) | Traditional Chinese medicine for treating chronic aplastic anemia | |
| CN101983681A (en) | Medicament for treating abnormal leucorrhea | |
| CN101979073A (en) | Medicament for soothing liver and regulating Qi | |
| CN101979072A (en) | Chinese medicament for treating chronic liver disease | |
| CN101983719A (en) | Novel medicament for treating lung cancer | |
| CN101983676A (en) | Medicament for treating gynecological blood stasis and qi stagnation | |
| CN101983645A (en) | Medicament for treating acute appendicitis | |
| CN101979010A (en) | Chinese medicament for treating metrorrhagia |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20110601 |